BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23540378)

  • 1. [Glycaemic control and complications of diabetes: what about?].
    Bouhanick B; Barigou M; Kantambadouno JB; Chamontin B
    Presse Med; 2013 May; 42(5):849-54. PubMed ID: 23540378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes: target HbA1c of about 7%.
    Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
    Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
    Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular complications of diabetes: is there a glycemic threshold?].
    Isnard F; Eschwège E
    Rev Prat; 2001 Oct; 51(16):1759-64. PubMed ID: 11795118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of the month. The STENO-2 study: a plea for global and intensive management of the type 2 diabetic patient].
    Scheen AJ; Estrella F
    Rev Med Liege; 2003 Feb; 58(2):109-11. PubMed ID: 12693313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tight glycemic control? Negative.
    Raskin P
    Hosp Pract (Off Ed); 1992 Feb; 27 Suppl 1():21-4; discussion 24-5. PubMed ID: 1347535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
    J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Not Available].
    Keller U
    Ther Umsch; 2017; 74(8):454-461. PubMed ID: 29461146
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2 diabetes and HbA1c targets.
    Prescrire Int; 2008 Dec; 17(98):254. PubMed ID: 19425272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
    Ismail-Beigi F; Craven T; Banerji MA; Basile J; Calles J; Cohen RM; Cuddihy R; Cushman WC; Genuth S; Grimm RH; Hamilton BP; Hoogwerf B; Karl D; Katz L; Krikorian A; O'Connor P; Pop-Busui R; Schubart U; Simmons D; Taylor H; Thomas A; Weiss D; Hramiak I;
    Lancet; 2010 Aug; 376(9739):419-30. PubMed ID: 20594588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy in patients with type 1 diabetes 4 years after intensive therapy.
    Bressler SB; Bressler NM
    Arch Ophthalmol; 2000 Jul; 118(7):984-5. PubMed ID: 10910526
    [No Abstract]   [Full Text] [Related]  

  • 14. Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.
    Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():3-8. PubMed ID: 24034513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glycemic control and diabetic complications].
    Yamada Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
    [No Abstract]   [Full Text] [Related]  

  • 16. [The study of development and progression of long-term complications in type I diabetes].
    Araki E; Matsumura T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.
    BMJ; 1995 Oct; 311(7011):973-7. PubMed ID: 7580637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the "gift" that keeps on giving!
    Cefalu WT; Ratner RE
    Diabetes Care; 2014; 37(1):5-7. PubMed ID: 24356590
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
    Reichard P; Nilsson BY; Rosenqvist U
    N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.